Oxidized mannan-MOG35-55 conjugate as a basis for targeted immune modulation in multiple sclerosis - Top-Institutions - MDSpire

Oxidized mannan-MOG35-55 conjugate as a basis for targeted immune modulation in multiple sclerosis

  • By

  • Athanasia Mouzaki

  • Anne-Lise de Lastic

  • Vasso Apostolopoulos

  • Ioannis Matsoukas

  • April 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

  • #4

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Neurology
    • Immunology
    • Multiple Sclerosis

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, N/A

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Multiple Sclerosis

Original Source(s)

Oxidized mannan-MOG35-55 conjugate as a basis for targeted immune modulation in multiple sclerosis

  • by Athanasia Mouzaki, Anne-Lise de Lastic, Vasso Apostolopoulos, Ioannis Matsoukas

  • April 28, 2026

Related Content

Jump assessment on a force plate—an approach to quantify subtle lower limb neuromuscular deficits in people with multiple sclerosis

Epstein-Barr Virus-Associated Multiple Sclerosis: Recent Mechanistic Advances and Clinical Therapeutic Perspectives

Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments